FIELD: medicine.
SUBSTANCE: invention refers to paediatrics and can be used for determination of tactics of treatment of children with acute infectious mononucleosis. Blood is taken from the patient. If observing herpesvirus DNA and blood serum neopterin level higher than 2.5 nmol/l, antiviral preparations are used as part of the complex therapy.
EFFECT: method provides higher clinical effectiveness in children with infectious mononucleosis ensured by the pathogenetically grounded therapeutic approach involving detection of herpesvirus DNA and blood serum neopterin.
1 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING EFFECTIVENESS OF ANTIVIRAL THERAPY IN INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2023 |
|
RU2821177C1 |
| METHOD FOR ASSESSING EFFECTIVENESS OF ANTIVIRAL THERAPY IN INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2023 |
|
RU2823996C1 |
| METHOD OF ASSESSING THE SEVERITY OF ACUTE INFECTIOUS MONONUCLEOSIS CAUSED BY THE EPSTEIN-BARR VIRUS IN CHILDREN | 2022 |
|
RU2798079C1 |
| METHOD OF PREDICTING RELAPSE OF EPSTEIN-BARR VIRAL INFECTION IN CHILDREN | 2023 |
|
RU2820959C1 |
| METHOD OF DETERMINING TACTICS OF TREATING CHILDREN WITH CHRONIC GASTRODUODENITIS | 2012 |
|
RU2526167C2 |
| METHOD FOR PREDICTING HUMAN TYPE 6 HERPES VIRUS INFECTION IN CHILDREN | 2018 |
|
RU2695323C1 |
| METHOD FOR DIAGNOSING THE SEVERITY OF EPSTEIN-BARR VIRUS-INDUCED ACUTE INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2022 |
|
RU2797960C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
| DIAGNOSTIC TECHNIQUE FOR THE COMBINED INFECTION IN CHILDREN WITH ACUTE RESPIRATORY INFECTIONS | 2019 |
|
RU2706126C1 |
| METHOD FOR ASSESSMENT OF ACTIVITY OF INFECTION CAUSED BY HERPES TYPE 4, 5 AND 6 IN CHILDREN | 2016 |
|
RU2639593C1 |
